BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND CDH1, uvomorulin, 999, P12830, ENSG00000039068, CDHE, Arc-1, UVO, LCAM, CD324, ECAD AND Treatment
49 results:

  • 1. [Effects of preoperative diagnostic hysteroscopy on peritoneal cytology and prognosis in patients with non-endometrioid carcinoma].
    Zhai ZY; Yang L; Li H; Li LW; Shen ZH; Zhang XB; Wang ZQ; Wang JL
    Zhonghua Fu Chan Ke Za Zhi; 2023 Dec; 58(12):903-910. PubMed ID: 38123196
    [No Abstract]    [Full Text] [Related]  

  • 2. HIV gp120/Tat protein-induced epithelial-mesenchymal transition promotes the progression of cervical lesions.
    Wang P; Yang B; Huang H; Liang P; Long B; Chen L; Yang L; Tang L; Huang L; Liang H
    AIDS Res Ther; 2023 Nov; 20(1):82. PubMed ID: 37981694
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Outcomes of dostarlimab versus chemotherapy in post-platinum patients with recurrent/advanced endometrial cancer: data from the GARNET trial and the National cancer Registration Service in England.
    Goulden S; Heffernan K; Sen Nikitas F; Shukla U; Knott C; Hunger M; Pahwa A; Schade R
    Int J Gynecol Cancer; 2023 Nov; 33(11):1715-1723. PubMed ID: 37620100
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Previously treated recurrent or advanced endometrial cancer in England: A real-world observational analysis.
    Heffernan K; Nikitas FS; Shukla U; Camejo HS; Knott C
    Gynecol Oncol; 2022 Aug; 166(2):317-325. PubMed ID: 35752507
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Genomic Profiling and Response to Immune Checkpoint Inhibition plus Tyrosine Kinase Inhibition in FH-Deficient Renal Cell Carcinoma.
    Xu Y; Kong W; Cao M; Wang J; Wang Z; Zheng L; Wu X; Cheng R; He W; Yang B; Dong B; Pan J; Chen Y; Huang J; Jiang C; Zhai W; Li F; Chen R; Zhou X; Wu G; Geng X; Chen J; An H; Yuan Y; Xu T; Chen D; Lin D; Xu L; Huang K; Peng L; Yu Y; Tai S; Qi H; Luo K; Kang X; Wang H; Huang Y; Zhang J; Xue W
    Eur Urol; 2023 Feb; 83(2):163-172. PubMed ID: 35715365
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. treatment outcomes and complications in FIGO stage IIIC and IVB endometrioid endometrial cancer patients presenting as nodal spreads following systematic lymphadenectomy and adjuvant therapy.
    Kong TW; Jo E; Son JH; Paek J; Chang SJ; Ryu HS
    J Obstet Gynaecol Res; 2021 Sep; 47(9):3322-3330. PubMed ID: 34196087
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. PET-CT radiomics by integrating primary tumor and peritumoral areas predicts E-cadherin expression and correlates with pelvic lymph node metastasis in early-stage cervical cancer.
    Li XR; Jin JJ; Yu Y; Wang XH; Guo Y; Sun HZ
    Eur Radiol; 2021 Aug; 31(8):5967-5979. PubMed ID: 33528626
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Dynamic analysis of circulating tumor DNA to predict prognosis and monitor therapeutic response in metastatic relapsed cervical cancer.
    Tian X; Ge D; Zhang F; Zhang B; Bai W; Xu X; Li Z; Cao Y; Li P; Zou K; Zou L
    Int J Cancer; 2021 Feb; 148(4):921-931. PubMed ID: 33113150
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Comparative study on the oncological prognosis of laparoscopy and laparotomy for stage IIA1 cervical squamous cell carcinoma.
    Chen C; Fang Z; Wang Q; Li W; Li P; Wang L; Kang S; Zhu B; Lin Z; Wang X; Wang L; Fan H; Bin X; Lang J; Liu P
    Eur J Surg Oncol; 2021 Feb; 47(2):346-352. PubMed ID: 32859433
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Race-driven survival differential in women diagnosed with endometrial cancers in the USA.
    Horne ZD; Teterichko SR; Glaser SM; Wegner RE; Hasan S; Crafton SM; Miller EM; Krivak TC; Viswanathan A; Olawaiye AB; Sukumvanich P; Beriwal S
    Int J Gynecol Cancer; 2020 Dec; 30(12):1893-1901. PubMed ID: 32847996
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Randomized Study Comparing a Reusable Morcellator with a Resectoscope in the Hysteroscopic treatment of uterine Polyps: The RESMO Study.
    Stoll F; Lecointre L; Meyer N; Faller E; Host A; Hummel M; Boisrame T; Akladios C; Garbin O
    J Minim Invasive Gynecol; 2021 Apr; 28(4):801-810. PubMed ID: 32681995
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Urinary symptoms in women receiving carboplatin/paclitaxel for treatment of gynecologic cancers.
    Strauchon CJ; Dengler KL; Gruber DD; Katebi Kashi P; Aungst MJ; Trikhacheva A; Bicher A; Von Pechmann W
    Int J Gynecol Cancer; 2020 Sep; 30(9):1418-1423. PubMed ID: 32655011
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Preliminary survey of 3D image-guided brachytherapy for cervical cancer at representative hospitals in Asian countries.
    Okonogi N; Wakatsuki M; Mizuno H; Fukuda S; Cao J; Kodrat H; Lau FN; Calaguas MJ; de Los Reyes RH; Chansilpa Y; Uddin AFMK; Adylkhanov T; Cho CK; Tsegmed U; Hoang NC; Ohno T; Nakano T; Kato S;
    J Radiat Res; 2020 Jul; 61(4):608-615. PubMed ID: 32367130
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Needle-free cervical cancer treatment using helical multishield intracavitary rotating shield brachytherapy with the
    Hopfensperger KM; Adams Q; Kim Y; Wu X; Xu W; Patwardhan K; Thammavong B; Caster J; Flynn RT
    Med Phys; 2020 Jun; 47(5):2061-2071. PubMed ID: 32073669
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Radiomic analysis for pretreatment prediction of response to neoadjuvant chemotherapy in locally advanced cervical cancer: A multicentre study.
    Sun C; Tian X; Liu Z; Li W; Li P; Chen J; Zhang W; Fang Z; Du P; Duan H; Liu P; Wang L; Chen C; Tian J
    EBioMedicine; 2019 Aug; 46():160-169. PubMed ID: 31395503
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. hsa_circ_0000745 promotes cervical cancer by increasing cell proliferation, migration, and invasion.
    Jiao J; Zhang T; Jiao X; Huang T; Zhao L; Ma D; Cui B
    J Cell Physiol; 2020 Feb; 235(2):1287-1295. PubMed ID: 31256433
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. 18F-FDG-PET/CT imaging of uterine cervical cancer recurrence in women with and without HIV infection.
    Lawal IO; Ololade KO; Popoola GO; Ankrah AO; Vorster M; Maes A; Mokgoro NP; van de Wiele C; Sathekge MM
    Q J Nucl Med Mol Imaging; 2022 Mar; 66(1):52-60. PubMed ID: 31089075
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Examining Urban and Rural Differences in How Distance to Care Influences the Initiation and Completion of treatment among Insured Cervical cancer Patients.
    Spees LP; Brewster WR; Varia MA; Weinberger M; Baggett C; Zhou X; Petermann VM; Wheeler SB
    Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):882-889. PubMed ID: 30733307
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Evaluating the urban-rural paradox: The complicated relationship between distance and the receipt of guideline-concordant care among cervical cancer patients.
    Spees LP; Wheeler SB; Varia M; Weinberger M; Baggett CD; Zhou X; Petermann VM; Brewster WR
    Gynecol Oncol; 2019 Jan; 152(1):112-118. PubMed ID: 30442384
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Transcriptomic Characterization of Endometrioid, Clear Cell, and High-Grade Serous Epithelial Ovarian Carcinoma.
    Fridley BL; Dai J; Raghavan R; Li Q; Winham SJ; Hou X; Weroha SJ; Wang C; Kalli KR; Cunningham JM; Lawrenson K; Gayther SA; Goode EL
    Cancer Epidemiol Biomarkers Prev; 2018 Sep; 27(9):1101-1109. PubMed ID: 29967001
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 3.